# A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older

> **NCT02366962** · PHASE3 · COMPLETED · sponsor: **UMN Pharma Inc.** · enrollment: 55 (actual)

## Conditions studied

- Influenza
- Vaccine

## Interventions

- **BIOLOGICAL:** ASP7374

## Key facts

- **NCT ID:** NCT02366962
- **Lead sponsor:** UMN Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02366962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02366962, "A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or Older". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02366962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*